Article

Diversity and level of evidence evaluation of commercial pharmacogenomic testing for mental health

2022-11-08

Abstract excerpt

This study examined arrays offered by commercial pharmacogenomic (PGx) testing services for mental health care in Australia and the United States, with a focus on utility for non-European populations. Seven of the 14 testing services we identified provided the manifests of their arrays. We examined allele frequencies for each variant using data from the Allele Frequency Aggregator 1 (ALFA), genome Aggregation Data...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 793fd9c9-8013-5db3-93c5-a1281e7a1a1d
DOI: 10.1101/2022.11.07.22282051

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Diversity and level of evidence evaluation of commercial pharmacogenomic testing for mental healthDOI 10.1101/2022.11.07.22282051Read

Pharmacogenetics in Psychiatry: An Update on Clinical UsabilitySemantic proximity Read

CYP2D6 and CYP2C19 Variant Coverage of Commercial Antidepressant Pharmacogenomic Testing Panels Available in Victoria, AustraliaSemantic proximity Read

Pharmacogenetic Testing Options Relevant to Psychiatry in Canada: Options de tests pharmacogénétiques pertinents en psychiatrie au Canada.Semantic proximity Read

Analytical and Clinical Validation of Action PharmaKitDx: A Comprehensive NGS Panel for the Identification of Pharmacogenetic Variants in Diverse PopulationsSemantic proximity Read

Genome Sequencing Enhances Precision and Clinical Utility of Pharmacogenetic Data Compared to Arrays.Semantic proximity Read

Horizon Scan Of Clinical Laboratories Offering Pharmacogenetic Testing.Semantic proximity Read

The landscape of pharmacogenetic testing in a US managed care populationSemantic proximity Read

Psychiatric pharmacogenomic testing in clinical practiceSemantic proximity Read

Pharmacogenomic allele coverage of genome-wide genotyping arrays: a comparative analysis.Semantic proximity Read

Standardized biogeographic grouping system for annotating populations in pharmacogenetic researchSemantic proximity Read

Navigating the Labyrinth of Pharmacogenetic Testing: A Guide to Test SelectionSemantic proximity Read

Systematic evaluation of commercial pharmacogenetic testing in psychiatry: a focus on CYP2D6 and CYP2C19 allele coverage and results reporting.Semantic proximity Read